LUXI, NICOLETTA
 Distribuzione geografica
Continente #
EU - Europa 147
NA - Nord America 145
AS - Asia 45
AF - Africa 1
Totale 338
Nazione #
US - Stati Uniti d'America 145
IT - Italia 65
CN - Cina 18
IE - Irlanda 17
SG - Singapore 15
SE - Svezia 13
FR - Francia 12
DE - Germania 10
RU - Federazione Russa 10
FI - Finlandia 8
GB - Regno Unito 6
KR - Corea 5
NL - Olanda 5
IN - India 3
JP - Giappone 2
HK - Hong Kong 1
PL - Polonia 1
SC - Seychelles 1
TR - Turchia 1
Totale 338
Città #
Chandler 40
Ashburn 21
Verona 21
Dublin 15
New York 11
Singapore 10
Beijing 8
Catania 6
Amsterdam 5
Boydton 5
Chions 5
Misterbianco 5
Seattle 5
Seoul 5
Southend 5
Boardman 4
Lawrence 4
Monserrato 4
Princeton 4
Redmond 4
Helsinki 3
Hyderabad 3
Palermo 3
Sindelfingen 3
Cernusco sul Naviglio 2
Darmstadt 2
Lappeenranta 2
Mezzocorona 2
Padova 2
Parabiago 2
Tokyo 2
Trento 2
Washington 2
Cesena 1
Dongguan 1
Fuzhou 1
Hanover 1
Hong Kong 1
Roverbella 1
San Francisco 1
Saronno 1
Tappahannock 1
Warsaw 1
Wilmington 1
Woodbridge 1
Totale 229
Nome #
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 64
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 60
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study 46
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 39
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy 29
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System 23
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 21
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports 18
Anaphylaxis due to antiallergic and antiasthmatic biologics 17
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study 14
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database 12
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study 11
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose 10
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study 9
Survey on maintenance immunosuppressive therapy in patients undergoing solid organ transplantation: experiences from Italian transplant centers 5
Totale 378
Categoria #
all - tutte 2.030
article - articoli 2.030
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 7 0 2 13 2 2 1 1 0 2 14
2022/2023142 14 14 6 23 2 24 0 12 15 5 20 7
2023/2024171 4 21 13 12 13 22 10 11 7 24 17 17
2024/202521 21 0 0 0 0 0 0 0 0 0 0 0
Totale 378